If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

AMYPAD Diagnostic and Patient Management Study: Rationale and design

Frisoni, G. B., Barkhof, F., Altomare, D., Berkhof, J., Boccardi, M., Canzoneri, E., Collij, L., Drzezga, A., Farrar, G., Garibotto, V., Gismondi, R., Gispert, J-D., Jessen, F., Kivipelto, M., Lopes Alves, I., Molinuevo, J-L., Nordberg, A., Payoux, P., Ritchie, C., Savicheva, I. & 8 othersScheltens, P., Schmidt, M. E., Schott, J., Stephens, A., van Berckel, B., Vellas, B., Walker, Z. & Raffa, N., Mar 2019, In : Alzheimers & Dementia. 15, 3, p. 388-399

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

DESGESCO (Dementia Genetics Spanish Consortium), EADB (Alzheimer Disease European DNA biobank), 27 May 2019, In : Acta Neuropathologica.

Research output: Contribution to journalArticleAcademicpeer-review

Activities 2010 2017

  • 7 Membership of board
  • 7 Membership of council
  • 5 Membership of committee

Translational Neuroscience Network Conference 2017 (Event)

Jeroen Hoozemans (Chair), MM Schoonheim (Chair), MMM Wilhelmus (Chair), P Scheltens (Chair), AB Brussaard (Chair)
12 Oct 2017

Activity: MembershipMembership of board

AC Immune SA (External organisation)

Philip Scheltens (Chair)
2017 → …

Activity: MembershipMembership of council

Toyama Pharma (External organisation)

Philip Scheltens (Chair)
2017 → …

Activity: MembershipMembership of council

Biogen Inc., Cambridge, Massachusetts 02142, USA. (External organisation)

Philip Scheltens (Chair)
2017 → …

Activity: MembershipMembership of council

EIP Pharma LLC (External organisation)

Philip Scheltens (Chair)
2016 → …

Activity: MembershipMembership of council